Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Breast Cancer Research and Treatment|July 3, 2015
Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancerAmanda J Schech, Preeti Shah, Stephen Yu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Effects of the antiestrogen tamoxifen and the aromatase inhibitor letrozole on serum hormones and bone characteristics in a preclinical tumor model for breast cancerNomelí P Núñez, Danijela Jelovac, Luciana Macedo, et al.Cancer Prevention Research (Philadelphia, Pa.)|October 5, 2012
Obesity, energy balance, and cancer: new opportunities for preventionStephen D Hursting, John Digiovanni, Andrew J Dannenberg, et al.Molecular Cancer Therapeutics|August 28, 2015
Seribantumab, an Anti-ERBB3 Antibody, Delays the Onset of Resistance and Restores Sensitivity to Letrozole in an Estrogen Receptor-Positive Breast Cancer ModelMichael D Curley, Gauri J Sabnis, Lucia Wille, et al.Proceedings of the National Academy of Sciences of the United States of America|July 5, 2005
The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cellsYuexing Zhang, Xin-Wei Wang, Danijela Jelovac, et al.Cancer Research|November 2, 2011
Dual IGF-1R/InsR inhibitor BMS-754807 synergizes with hormonal agents in treatment of estrogen-dependent breast cancerXiaonan Hou, Fei Huang, Luciana F Macedo, et al.Cancer Research|August 17, 2006
Tyrosine kinase Etk/BMX is up-regulated in human prostate cancer and its overexpression induces prostate intraepithelial neoplasia in mouseBojie Dai, Oekyung Kim, Yingqiu Xie, et al.Science Translational Medicine|July 24, 2015
The prodrug DHED selectively delivers 17β-estradiol to the brain for treating estrogen-responsive disordersLaszlo Prokai, Vien Nguyen, Szabolcs Szarka, et al.Cancer Research|January 21, 2016
Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast CancerVanessa F Merino, Nguyen Nguyen, Kideok Jin, et al.Pageof 4